Pharmaceutical composition comprising a cannabinoid Grant US-11806319-B2 United States of America 07 Nov 2023
Use of cannabinoids in the treatment of epilepsy Grant US-11766411-B2 United States of America 26 Sep 2023
Use of cannabinoids in the treatment of epilepsy Grant US-11701330-B2 United States of America 18 Jul 2023
Use of cannabinoids in the treatment of epilepsy Grant US-11684598-B2 United States of America 27 Jun 2023
Use of cannabinoids in the treatment of Angelman syndrome Grant US-11679087-B2 United States of America 20 Jun 2023
Use of cannabinoids in the treatment of epilepsy Grant US-11633369-B2 United States of America 25 Apr 2023
USE OF CANNABIDIOL IN THE TREATMENT OF AICARDI SYNDROME Grant EP-3206679-B1 European Patent Office 30 Nov 2022
Use of cannabinoids in the treatment of epilepsy Grant US-11446258-B2 United States of America 20 Sep 2022
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus Grant US-11406623-B2 United States of America 09 Aug 2022
Use of cannabidiol in the treatment of epilepsy Grant US-11400055-B2 United States of America 02 Aug 2022
Use of cannabinoids in the treatment of epilepsy Grant US-11357741-B2 United States of America 14 Jun 2022
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and… Grant US-11318109-B2 United States of America 03 May 2022
COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION Application WO-2022024095-A3 World Intellectual Property Organisation (WIPO) 10 Mar 2022
ANTIVIRAL COMPOSITIONS AND METHODS FOR THEIR USE Application WO-2022024097-A1 World Intellectual Property Organisation (WIPO) 03 Feb 2022
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus Grant US-11160795-B2 United States of America 02 Nov 2021
pH dependent release coated microparticle cannabinoid formulations Grant US-11160757-B1 United States of America 02 Nov 2021
Use of cannabinoids in the treatment of epilepsy Grant US-11154517-B2 United States of America 26 Oct 2021
Use of cannabinoids in the treatment of epilepsy Grant US-11154516-B2 United States of America 26 Oct 2021
Use of cannabinoids in the treatment of epilepsy Grant US-11147783-B2 United States of America 19 Oct 2021
Use of cannabinoids in the treatment of epilepsy Grant US-11096905-B2 United States of America 24 Aug 2021
Use of cannabidiol in the treatment of epilepsy Grant US-11065209-B2 United States of America 20 Jul 2021
Use of cannabinoids in the treatment of multiple myeloma Grant US-11065227-B2 United States of America 20 Jul 2021
Use of cannabinoids in the treatment of epilepsy Grant US-10966939-B2 United States of America 06 Apr 2021
Use of cannabinoids in the treatment of epilepsy Grant US-10849860-B2 United States of America 01 Dec 2020
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and… Grant US-10729665-B2 United States of America 04 Aug 2020
USE OF CANNABINOIDS IN THE TREATMENT OF ATONIC SEIZURES IN LENNOX-GASTAUT SYNDROME Grant EP-3206716-B1 European Patent Office 29 Jul 2020
Use of cannabinoids in the treatment of epilepsy Grant US-10709674-B2 United States of America 14 Jul 2020
Use of cannabinoids in the treatment of epilepsy Grant US-10709673-B2 United States of America 14 Jul 2020
Use of cannabinoids in the treatment of epilepsy Grant US-10603288-B2 United States of America 31 Mar 2020
Use of cannabinoids in the treatment of epilepsy Grant US-10583096-B2 United States of America 10 Mar 2020
USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY Application EP-3206679-A1 European Patent Office 23 Aug 2017